<DOC>
	<DOCNO>NCT00344799</DOCNO>
	<brief_summary>Patients diagnose choroidal melanoma undergo I-125 plaque enucleation surgery consent participate study . A tumor sample take surgery study lab genetic feature . These feature feature subject ' clinical course record . Analysis data may identify genetic feature indicative prognostic factor include risk metastasis .</brief_summary>
	<brief_title>Cytogenetic Study Ocular Melanoma</brief_title>
	<detailed_description>The Jules Stein Eye Institute Ocular Melanoma Research Group conduct cytogenetic study choroidal melanoma improve screen biopsy sample choroidal melanoma cytogenetic analysis . Our goal identify molecular probe specifically target region chromosome undergo change characteristic metastatic choroidal melanoma .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>1 . Patient diagnosis ocular melanoma 2 . Patient local treatment plan ocular melanoma plaque brachytherapy enucleation 3 . Patient 18 year age old 4 . Archival enucleation specimen diagnosis ocular melanoma 1 . Patient refuse local melanoma treatment 2 . Patient refuse participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Choroidal Melanoma</keyword>
	<keyword>Choroidal Malignant Melanoma</keyword>
	<keyword>Ocular Melanoma</keyword>
	<keyword>Uveal Melanoma</keyword>
</DOC>